BioxList.
2025 US Biotech Investor List – Therapeutics Focus + Direct Emails
2025 US Biotech Investor List – Therapeutics Focus + Direct Emails
Couldn't load pickup availability
Access 266 U.S. Investors Targeted in Therapeutics Innovation. Now with Direct Employee Contacts to Accelerate Your Fundraising.
What’s Inside:
🔥Direct Employee Emails: First-name contacts (Partners, Associates, Principals) at Investors' firms.
🏢 Company Names: 266 U.S.-based investors actively investing in Therapeutics (drug discovery, rare diseases, oncology, etc.).
📍Headquarters Locations: Indicates all other countries where their offices also operate.
🌐 Website URLs: Direct access to investor profiles and portfolios.
💸 Investment Stages: Filter by focus (Seed, Series A, etc.) to align with your goals.
💰 Ticket Sizes: Know exact investment ranges (e.g., 250K–10M) to target the right partners.
📧 Backup Channels: Generic emails included for alternative outreach.
(You’ll receive an Excel file + a CSV file packed with direct partner emails for precision outreach.)
Want an in-depth look at every data point? Click here to discover all the details.
Why This List is Made for You:
Stop cold outreach. Pitch Partners directly at firms funding your niche.
Save 100+ hours researching get a curated list of decision-makers who care about your science.
Just Results:
This isn’t a generic directory it’s a strategic tool built for accuracy and action. Save hundreds of hours on prospecting, avoid dead-end leads, and focus on what matters: building relationships that drive growth.
Download now and unlock 266 strategic connections.
Data freshness: Updated April 4 2025
Need specifics? Contact our data team here.
Data sourced from proprietary research
Share

